Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

SRIDHAR R BOLLA

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1316994148
CMS profile
59541
Location
AVON, IN

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$4,557.82

210 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $4,152.06 203
Education $206.36 5
Long term medical supply or device loan $199.40 2

By paying entity

PY2022 · entire year · sorted by reported total

Paying entityAmountRecords
Novartis Pharmaceuticals Corporation $485.01 18
E.R. Squibb & Sons, L.L.C. $439.93 17
GENZYME CORPORATION $296.82 9
Daiichi Sankyo Inc. $227.27 10
EISAI INC. $221.37 12
Janssen Biotech, Inc. $220.57 11
Merck Sharp & Dohme LLC $175.99 9
PFIZER INC. $170.43 11
SANOFI-AVENTIS U.S. LLC $159.98 2
Incyte Corporation $158.36 11
Seagen Inc. $117.97 7
AstraZeneca Pharmaceuticals LP $110.43 5
Exelixis Inc. $104.58 5
Acrotech Biopharma LLC $95.68 3
ABBVIE INC. $92.69 4
Rigel Pharmaceuticals, Inc. $85.44 3
Amgen Inc. $83.07 5
Celgene Corporation $81.23 5
Janssen Pharmaceuticals, Inc $80.94 4
Kite Pharma, Inc. $68.63 3
Gilead Sciences, Inc. $65.08 4
Lilly USA, LLC $64.60 4
GlaxoSmithKline, LLC. $63.27 3
Pharmacosmos Therapeutics Inc. $63.16 3
TG Therapeutics, Inc. $60.22 1
Pharmacyclics LLC, an AbbVie Company $56.53 3
PharmaEssentia USA Corporation $55.69 3
Astellas Pharma US Inc $53.67 3
Global Blood Therapeutics, Inc. $44.40 3
Ipsen Biopharmaceuticals, Inc $42.54 2
Genmab U.S., Inc. $38.85 2
Alexion Pharmaceuticals, Inc. $36.58 2
JAZZ PHARMACEUTICALS INC. $36.08 1
Genentech USA, Inc. $33.57 2
CTI BioPharma Corp. $29.09 1
Deciphera Pharmaceuticals Inc. $26.99 1
MACROGENICS, INC. $24.86 1
Takeda Pharmaceuticals U.S.A., Inc. $24.81 1
Nestle HealthCare Nutrition Inc. $24.78 1
BeiGene USA, Inc. $24.76 2
Stemline Therapeutics Inc. $22.18 1
TOLMAR Pharmaceuticals, Inc. $20.93 1
Coherus Biosciences Inc. $20.80 1
Agios Pharmaceuticals, Inc. $20.31 1
Taiho Oncology, Inc. $18.56 1
MorphoSys, US Inc. $15.54 1
Regeneron Healthcare Solutions, Inc. $14.91 1
Boehringer Ingelheim Pharmaceuticals, Inc. $14.33 1
PUMA BIOTECHNOLOGY, INC. $13.35 1
Foundation Medicine, Inc. $13.13 1
Bayer HealthCare Pharmaceuticals Inc. $12.95 1
Kyowa Kirin, Inc. $12.53 1
ARRAY BIOPHARMA INC $12.38 1

Page 2 of 5; records 51–100 of 210 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

SRIDHAR R BOLLA

NPI 1316994148 · CMS profile ID 59541

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

AVON, IN

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 5; records 51–100 of 210 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1316994148?year=2022&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
SRIDHAR R BOLLA, NPI 1316994148, CMS profile ID 59541. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 5; records 51–100 of 210 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1316994148?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). SRIDHAR R BOLLA, NPI 1316994148, CMS profile ID 59541. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 5; records 51–100 of 210 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1316994148?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
SRIDHAR R BOLLA, NPI 1316994148, CMS profile ID 59541, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 5; records 51–100 of 210 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1316994148?year=2022&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

210 matching records · $4,557.82 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 210 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 210.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Daiichi Sankyo Inc. $22.4910/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930867305 CMS
Seagen Inc. $0.3610/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 904109643 CMS
Seagen Inc. $12.5910/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 904109645 CMS
ABBVIE INC. $34.0010/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890632403 CMS
Lilly USA, LLC $16.2310/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 918368809 CMS
E.R. Squibb & Sons, L.L.C. $20.1410/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932640651 CMS
E.R. Squibb & Sons, L.L.C. $0.2310/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932640653 CMS
GENZYME CORPORATION $34.5610/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938908115 CMS
Incyte Corporation $19.1210/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 943021723 CMS
Incyte Corporation $0.2710/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 943021725 CMS
E.R. Squibb & Sons, L.L.C. $24.4910/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932640649 CMS
Ipsen Biopharmaceuticals, Inc $21.1010/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893401299 CMS
GENZYME CORPORATION $85.0010/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938908213 CMS
Genentech USA, Inc. $15.8110/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 950757469 CMS
Janssen Pharmaceuticals, Inc $22.4210/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 886197111 CMS
Novartis Pharmaceuticals Corporation $16.4810/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893537625 CMS
EISAI INC. $13.5309/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908088833 CMS
Global Blood Therapeutics, Inc. $12.8609/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 942707889 CMS
Pharmacosmos Therapeutics Inc. $20.7009/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 959138597 CMS
Genmab U.S., Inc. $16.6209/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 921580843 CMS
Acrotech Biopharma LLC $16.0209/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937454421 CMS
Incyte Corporation $15.9509/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 943021717 CMS
E.R. Squibb & Sons, L.L.C. $22.0009/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932640655 CMS
Seagen Inc. $29.7909/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 904109603 CMS
PFIZER INC. $13.5709/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949318651 CMS
PFIZER INC. $21.0009/16/2022 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949428753 CMS
Janssen Pharmaceuticals, Inc $21.9309/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 886197099 CMS
Novartis Pharmaceuticals Corporation $17.9309/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893537631 CMS
PharmaEssentia USA Corporation $22.9109/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 941276511 CMS
Novartis Pharmaceuticals Corporation $20.4809/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893537623 CMS
Rigel Pharmaceuticals, Inc. $45.2009/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 962281017 CMS
Novartis Pharmaceuticals Corporation $17.8209/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893537621 CMS
Merck Sharp & Dohme LLC $18.3209/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944257567 CMS
Coherus Biosciences Inc. $20.8008/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 956562571 CMS
Alexion Pharmaceuticals, Inc. $18.7608/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914831793 CMS
Novartis Pharmaceuticals Corporation $15.9408/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893537619 CMS
Janssen Biotech, Inc. $28.2308/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885885105 CMS
Novartis Pharmaceuticals Corporation $19.7108/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893537617 CMS
Amgen Inc. $17.0008/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939814835 CMS
BeiGene USA, Inc. $11.8408/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940797023 CMS
E.R. Squibb & Sons, L.L.C. $13.7608/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932640641 CMS
GlaxoSmithKline, LLC. $22.2808/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944685487 CMS
MACROGENICS, INC. $24.8608/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 927057515 CMS
EISAI INC. $24.6608/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908088837 CMS
EISAI INC. $11.9608/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908088851 CMS
PFIZER INC. $12.6808/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949485555 CMS
Celgene Corporation $13.6707/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932640633 CMS
ABBVIE INC. $13.2507/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890632401 CMS
GENZYME CORPORATION $20.2907/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938908093 CMS
PFIZER INC. $12.7407/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949202579 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $6,780.46 201
PY2020 $1,590.33 83
PY2021 $2,757.65 132
PY2022 $4,557.82 210
PY2023 $4,847.54 220
PY2024 $3,782.62 146
PY2025 $4,221.19 160

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2021 Principal investigator $660.64 11
PY2020 Principal investigator $95,298.48 28
PY2019 Principal investigator $89,463.85 31

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

11 records in PY2021

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Incyte Corporation $1.80 10/08/2021 Non-covered Recipient Entity
AMERICAN HEALTH NETWORK OF INDIANA
PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBROSIS (MF) OR HIGH RISK ESSENTIAL THROMBOCYTHEMIA (ET) OR ET PATIENTS RECEIVING ET DIRECTED THERAPY No dispute reported 06/30/2026 831079701
Principal investigator 1 Incyte Corporation $22.80 10/08/2021 Non-covered Recipient Entity
AMERICAN HEALTH NETWORK OF INDIANA
PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBROSIS (MF) OR HIGH RISK ESSENTIAL THROMBOCYTHEMIA (ET) OR ET PATIENTS RECEIVING ET DIRECTED THERAPY No dispute reported 06/30/2026 831079707
Principal investigator 1 Incyte Corporation $109.80 10/08/2021 Non-covered Recipient Entity
AMERICAN HEALTH NETWORK OF INDIANA
PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBROSIS (MF) OR HIGH RISK ESSENTIAL THROMBOCYTHEMIA (ET) OR ET PATIENTS RECEIVING ET DIRECTED THERAPY No dispute reported 06/30/2026 831079715
Principal investigator 1 Incyte Corporation $114.00 10/08/2021 Non-covered Recipient Entity
AMERICAN HEALTH NETWORK OF INDIANA
PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBROSIS (MF) OR HIGH RISK ESSENTIAL THROMBOCYTHEMIA (ET) OR ET PATIENTS RECEIVING ET DIRECTED THERAPY No dispute reported 06/30/2026 831079721
Principal investigator 1 Incyte Corporation $76.64 06/08/2021 Non-covered Recipient Entity
AMERICAN HEALTH NETWORK OF INDIANA
PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBROSIS (MF) OR HIGH RISK ESSENTIAL THROMBOCYTHEMIA (ET) OR ET PATIENTS RECEIVING ET DIRECTED THERAPY No dispute reported 06/30/2026 831079325
Principal investigator 1 Incyte Corporation $20.40 06/08/2021 Non-covered Recipient Entity
AMERICAN HEALTH NETWORK OF INDIANA
PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBROSIS (MF) OR HIGH RISK ESSENTIAL THROMBOCYTHEMIA (ET) OR ET PATIENTS RECEIVING ET DIRECTED THERAPY No dispute reported 06/30/2026 831079331
Principal investigator 1 Incyte Corporation $79.80 03/08/2021 Non-covered Recipient Entity
AMERICAN HEALTH NETWORK OF INDIANA
PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBROSIS (MF) OR HIGH RISK ESSENTIAL THROMBOCYTHEMIA (ET) OR ET PATIENTS RECEIVING ET DIRECTED THERAPY No dispute reported 06/30/2026 831079265
Principal investigator 1 Incyte Corporation $76.86 03/08/2021 Non-covered Recipient Entity
AMERICAN HEALTH NETWORK OF INDIANA
PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBROSIS (MF) OR HIGH RISK ESSENTIAL THROMBOCYTHEMIA (ET) OR ET PATIENTS RECEIVING ET DIRECTED THERAPY No dispute reported 06/30/2026 831079271
Principal investigator 1 Incyte Corporation $2.10 03/08/2021 Non-covered Recipient Entity
AMERICAN HEALTH NETWORK OF INDIANA
PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBROSIS (MF) OR HIGH RISK ESSENTIAL THROMBOCYTHEMIA (ET) OR ET PATIENTS RECEIVING ET DIRECTED THERAPY No dispute reported 06/30/2026 831079277
Principal investigator 1 Incyte Corporation $76.64 03/08/2021 Non-covered Recipient Entity
AMERICAN HEALTH NETWORK OF INDIANA
PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBROSIS (MF) OR HIGH RISK ESSENTIAL THROMBOCYTHEMIA (ET) OR ET PATIENTS RECEIVING ET DIRECTED THERAPY No dispute reported 06/30/2026 831079283
Principal investigator 1 Incyte Corporation $79.80 03/08/2021 Non-covered Recipient Entity
AMERICAN HEALTH NETWORK OF INDIANA
PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBROSIS (MF) OR HIGH RISK ESSENTIAL THROMBOCYTHEMIA (ET) OR ET PATIENTS RECEIVING ET DIRECTED THERAPY No dispute reported 06/30/2026 831079289